Theratechnologies inc.
TSX : TH

Theratechnologies inc.

April 10, 2006 08:00 ET

Theratechnologies to Present at this Week's BIO 2006 Conference in Chicago

MONTREAL, QUEBEC--(CCNMatthews - April 10, 2006) - Theratechnologies (TSX:TH) announced today that Yves Rosconi, President and Chief Executive Officer of the Company, will present a corporate update at the BIO 2006 Conference, which will take place this week in Chicago. Mr. Rosconi will be speaking at 9:00 a.m., on Wednesday, April 12th. BIO is an important annual venue for biotechnology companies and brings together some 20,000 participants from 30 countries.

About Theratechnologies

Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers or acquires novel therapeutic products for development and commercialization. These products target unmet medical needs in commercially attractive specialty markets. The most advanced program is in Phase 3 clinical development in HIV-associated lipodystrophy. The Company also has other promising projects at various stages of development.

Contact Information